You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR CLARITIN REDITABS


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for CLARITIN REDITABS

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00762983 ↗ Observation of Use of Claritin (Loratadine) Tablet, RediTabs, and Dry Syrup in Children (Study P05834)(COMPLETED) Completed Merck Sharp & Dohme Corp. 2008-03-01 The purpose of this study is to collect information on unexpected adverse reactions (ADRs), how often ADRs occur, and factors that can affect the safety and effectiveness of Claritin (loratadine) when used in children. Patients will be observed while they are taking Claritin, and ADRs and symptom scores will be recorded. At the end of treatment, improvement in symptoms will be recorded. Post-marketing surveys are not considered applicable clinical trials and thus the results of this survey will not be posted at its conclusion. The results will be submitted to public health officials as required by applicable national and international laws.
NCT00776217 ↗ Bioequivalence Study on Loratadine Orally Disintegrating Tablets 10 mg Under Fasting Conditions Completed Ranbaxy Laboratories Limited N/A 2006-06-01 To compare the single-dose oral bioavailability of loratadine 10 mg orally disintegrating tablets of Ohm Laboratories (a subsidiary of Ranbaxy Pharmaceuticals Inc., USA) with Claritin® Reditabs® (containing loratadine 10 mg) of Schering-Plough Healthcare Product Inc., USA in healthy, adult, human male subjects under fasting condition.
NCT00776282 ↗ Bioequivalence Study of Loratadine Orally Disintegrating Tablets 10 mg Under Fed Conditions Completed Ranbaxy Laboratories Limited N/A 2006-07-01 To compare the single-dose oral bioavailability of loratadine 10 mg orally disintegrating tablets of Ohm Laboratories Inc (A subsidiary of Ranbaxy Pharmaceuticals, Inc. USA) with Claritin® Reditabs® (containing loratadine 10 mg) of Schering-Plough Healthcare Product Inc., USA in healthy, adult, human male subjects under fed condition.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for CLARITIN REDITABS

Condition Name

Condition Name for CLARITIN REDITABS
Intervention Trials
Healthy 2
Rhinitis, Allergic, Seasonal 1
Urticaria 1
Pruritus 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for CLARITIN REDITABS
Intervention Trials
Rhinitis, Allergic, Perennial 1
Rhinitis, Allergic 1
Rhinitis 1
Pruritus 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for CLARITIN REDITABS

Clinical Trial Phase

Clinical Trial Phase for CLARITIN REDITABS
Clinical Trial Phase Trials
N/A 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for CLARITIN REDITABS
Clinical Trial Phase Trials
Completed 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for CLARITIN REDITABS

Sponsor Name

Sponsor Name for CLARITIN REDITABS
Sponsor Trials
Ranbaxy Laboratories Limited 2
Merck Sharp & Dohme Corp. 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for CLARITIN REDITABS
Sponsor Trials
Industry 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.